THE ROLE OF MICRORNA 122 IN METABOLIC DYSFUNCTIONASSOCIATED STEATOTIC LIVER DISEASE

被引:0
|
作者
Tran, Khang [1 ]
Devaskar, Sherin [1 ]
Ghosh, Shubhamoy [2 ]
Calkins, Kara [1 ]
机构
[1] Univ Calif Los Angeles, Mattel Childrens Hosp, Los Angeles, CA 90024 USA
[2] Univ Calif Los Angeles, Los Angeles, CA 90024 USA
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
135
引用
收藏
页码:S88 / S89
页数:2
相关论文
共 50 条
  • [1] RECK and EGFR Signaling in Metabolic DysfunctionAssociated Steatotic Liver Disease
    Krause, Alexa
    Dashek, Ryan
    Flink, Jack
    Shryack, Grace
    Taylor, Christopher
    Meers, Grace
    Chandrasekar, Bysani
    Rector, R. Scott
    OBESITY, 2023, 31 : 217 - 218
  • [2] Barriers to Exercise in Patients With Metabolic DysfunctionAssociated Steatotic Liver Disease: A Patient Survey
    Deshpande, Kedar
    Olynyk, John
    Ayonrinde, Oyekoya
    Nosaka, Kazunori
    JOURNAL OF CLINICAL MEDICINE RESEARCH-CANADA, 2024, 16 (2-3): : 94 - 105
  • [3] Relationship Between Metabolic DysfunctionAssociated Steatotic Liver Disease and Lipoprotein (a) and Other Biomarkers
    Rossi, Felipe A. Munoz
    Agudelo, Juanita Salazar
    Castro, Nestor Israel Quinapanta
    Mosquera, Sofia Z.
    Fajardo, Maria Clara Mejia
    Lopez, Edgar Dario Mosquera
    Olarte, Jonathan Dany Espitia
    Medina, Maria Andrea Figueroa
    Simancas, Edwin Zuniga
    Osuna, Luis Fernando Saldarriaga
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (06)
  • [4] PUM1 KNOCKDOWN AGGRAVATES LIPID DEPOSITION IN METABOLIC DYSFUNCTIONASSOCIATED STEATOTIC LIVER DISEASE
    Wan, Zhiping
    Cai, Xiang
    Liu, Xiaoquan
    Yang, Xiaoan
    Chen, Haoqi
    Deng, Hong
    HEPATOLOGY, 2024, 80 : S45 - S45
  • [5] Body Composition in Patients With Metabolic Dysfunctionassociated Steatotic Liver Disease: Impact of Body Surface Area
    Onishi, Saori
    Fukuda, Akira
    Matsui, Masahiro
    Ushiro, Kosuke
    Nishikawa, Tomohiro
    Asai, Akira
    Kim, Soo Ki
    Nishikawa, Hiroki
    IN VIVO, 2024, 38 (04): : 1917 - 1926
  • [6] Multi-Functional Role of RECK in Metabolic DysfunctionAssociated Steatotic Liver Disease Development: A Mass Spectrometry-Proteomic Approach
    Dashek, Ryan
    Kelty, Taylor
    Krause, Alexa
    Taylor, Chris
    Meers, Grace
    Chandrasekar, Bysani
    Rector, R. Scott
    PHYSIOLOGY, 2024, 39
  • [7] VIRAL HEPATITIS WITH CONCURRENT METABOLIC DYSFUNCTIONASSOCIATED STEATOTIC LIVER DISEASE IS A SUBGROUP AT HIGH RISK FOR ADVANCED FIBROSIS
    Kim, David S.
    Le, Alexander
    Ismail, Mohamed
    Abboud, Yazan
    Khan, Wajiha
    Pyrsopoulos, Nikolaos T.
    Kim, Hyunseok
    Hajifathalian, Kaveh
    GASTROENTEROLOGY, 2024, 166 (05) : S1565 - S1566
  • [8] HUMAN HEPATIC 3D SPHEROIDS AS A MODEL FOR METABOLIC DYSFUNCTIONASSOCIATED STEATOTIC LIVER DISEASE ( MASLD)
    Choi, Mi-Sun
    Kim, Soojin
    Jegal, Hyun
    Lee, Ga-Won
    Oh, Jungh-Hwa
    HEPATOLOGY, 2024, 80 : S44 - S45
  • [9] STREPTOCOCCUS SALIVARIUS MITIGATES METABOLIC DYSFUNCTIONASSOCIATED STEATOTIC LIVER DISEASE BY MODULATING NLRP3 INFLAMMASOME PATHWAY
    Kim, Jeong Su
    Song, Seol Hee
    Park, JeongHa
    Kwon, Young Seok
    Kim, Dong Joon
    HEPATOLOGY, 2024, 80 : S62 - S63
  • [10] A RAT MODEL FOR METABOLIC DYSFUNCTIONASSOCIATED FATTY LIVER DISEASE
    Tsuchishima, Mutsumi
    Tsutsumi, Mikihiro
    George, Joseph
    HEPATOLOGY, 2023, 78 : S1064 - S1064